13F portfolio / Multi-strategy
Farallon Capital
Founded by Tom Steyer
Farallon Capital Management is a San Francisco investment firm founded by Tom Steyer in 1986.
It runs multi-strategy hedge funds. The 13F shows only its US-listed long equity and option positions.
- Reported 13F value
- $17.1B
- Positions
- 86
- Est. 1-yearEstimate
- +30.7%SPY +15.7%
- Est. 3-year, annualizedEstimate
- —SPY +22.8%
As of Jun 30, 2026 · filed Aug 14, 2026
Holdings
20 new · 29 added · 22 trimmed · 15 unchanged · 104 sold out
| 1 | RVMD on Yahoo Finance (opens in a new tab) | Revolution Medicines IncCOM | 14.9% | $2.5B | 13,550,796 | Unchanged | $35.00 | $177.00 | +405.7% |
| 2 | — | Electronic Arts IncCOM | 9.5% | $1.6B | 7,919,500 | Added +6.0% | — | — | — |
| 3 | BBIO on Yahoo Finance (opens in a new tab) | Bridgebio Pharma IncCOM | 4.7% | $800M | 10,743,063 | Added +14.7% | $40.03 | $66.08 | +65.1% |
| 4 | PTGX on Yahoo Finance (opens in a new tab) | Protagonist Therapeutics IncCOM | 4.6% | $778M | 6,348,906 | Unchanged | $21.95 | $127.72 | +481.9% |
| 5 | EXEL on Yahoo Finance (opens in a new tab) | Exelixis IncCOM | 4.3% | $733M | 13,468,010 | Added +2.7% | $25.81 | $61.96 | +140.0% |
| 6 | LQDA on Yahoo Finance (opens in a new tab) | Liquidia CorporationCOM NEW | 3.9% | $667M | 8,365,038 | Trimmed -3.4% | $17.60 | $33.77 | +91.8% |
| 7 | AMZN on Yahoo Finance (opens in a new tab) | Amazon Com IncCOM | 3.7% | $628M | 2,632,994 | Trimmed -37.6% | $207.70 | $249.20 | +20.0% |
| 8 | LNTH on Yahoo Finance (opens in a new tab) | Lantheus Hldgs IncCOM | 3.6% | $619M | 5,583,479 | Unchanged | $75.58 | $99.87 | +32.1% |
| 9 | NTRA on Yahoo Finance (opens in a new tab) | Natera IncCOM | 3.5% | $602M | 2,218,366 | Trimmed -30.8% | $68.43 | $391.99 | +472.8% |
| 10 | UNH on Yahoo Finance (opens in a new tab) | Unitedhealth Group IncCOM | 3.1% | $528M | 1,270,532 | Trimmed -30.3% | $430.93 | $401.73 | -6.8% |
| 11 | TMO on Yahoo Finance (opens in a new tab) | Thermo Fisher Scientific IncCOM | 3.1% | $526M | 1,049,185 | Added +19.0% | $503.93 | $686.14 | +36.2% |
| 12 | ROIV on Yahoo Finance (opens in a new tab) | Roivant Sciences LtdSHS | 3.0% | $506M | 14,309,000 | Added +47.9% | $26.90 | $33.43 | +24.3% |
| 13 | AON on Yahoo Finance (opens in a new tab) | Aon PLCSHS CL A | 2.7% | $459M | 1,382,562 | Trimmed -45.0% | $327.53 | $289.88 | -11.5% |
| 14 | BSX on Yahoo Finance (opens in a new tab) | Boston Scientific CorpCOM | 2.6% | $449M | 10,521,184 | Added +40.8% | $72.01 | $44.06 | -38.8% |
| 15 | AVGO on Yahoo Finance (opens in a new tab) | Broadcom IncCOM | 2.5% | $435M | 1,151,800 | Trimmed -35.3% | $341.22 | $332.05 | -2.7% |
| 16 | MSFT on Yahoo Finance (opens in a new tab) | Microsoft CorpCOM | 2.4% | $415M | 1,112,863 | Trimmed -52.5% | $392.28 | $526.88 | +34.3% |
| 17 | TNGX on Yahoo Finance (opens in a new tab) | Tango Therapeutics IncCOM | 2.2% | $384M | 12,277,000 | Added +35.0% | $9.92 | $22.19 | +123.7% |
| 18 | KKR on Yahoo Finance (opens in a new tab) | KKR & Co IncCOM | 2.2% | $378M | 4,118,300 | Trimmed -11.8% | $112.97 | $86.42 | -23.5% |
| 19 | SNPS on Yahoo Finance (opens in a new tab) | Synopsys IncCOM | 2.2% | $370M | 829,600 | Trimmed -31.6% | $445.61 | $451.08 | +1.2% |
| 20 | BEAM on Yahoo Finance (opens in a new tab) | Beam Therapeutics IncCOM | 2.1% | $351M | 10,236,396 | Added +1.0% | $25.14 | $23.26 | -7.5% |
| 21 | — | Crinetics Pharmaceuticals InCOM | 2.0% | $336M | 8,989,098 | Added +7.8% | — | — | — |
| 22 | GRAL on Yahoo Finance (opens in a new tab) | Grail IncCOM | 1.7% | $284M | 4,161,584 | Added +27.9% | $62.58 | $119.57 | +91.1% |
| 23 | WAB on Yahoo Finance (opens in a new tab) | WabtecCOM | 1.4% | $241M | 894,503 | Trimmed -44.4% | $155.13 | $286.45 | +84.7% |
| 24 | IMVT on Yahoo Finance (opens in a new tab) | Immunovant IncCOM | 1.3% | $224M | 5,805,000 | Added +275.5% | $29.25 | $26.54 | -9.3% |
| 25 | TWST on Yahoo Finance (opens in a new tab) | Twist Bioscience CorpCOM | 1.3% | $220M | 2,136,400 | Added +49.6% | $51.54 | $132.55 | +157.2% |
| 26 | AGIO on Yahoo Finance (opens in a new tab) | Agios Pharmaceuticals IncCOM | 1.3% | $220M | 5,917,400 | Added +4.1% | $25.94 | $31.76 | +22.4% |
| 27 | ARMK on Yahoo Finance (opens in a new tab) | AramarkCOM | 1.2% | $206M | 3,625,731 | Trimmed -40.9% | $29.29 | $55.40 | +89.1% |
| 28 | BIDU on Yahoo Finance (opens in a new tab) | Baidu IncSPON ADR REP A | 0.8% | $138M | 1,203,785 | Added +171.3% | $120.83 | $80.86 | -33.1% |
| 29 | NVO on Yahoo Finance (opens in a new tab) | Novo-Nordisk A SADR | 0.7% | $126M | 2,619,000 | Added +234.9% | $43.24 | $38.76 | -10.4% |
| 30 | ACHC on Yahoo Finance (opens in a new tab) | Acadia Healthcare Company InCOM | 0.7% | $125M | 4,220,800 | Added +143.0% | $22.56 | $30.12 | +33.5% |
| 31 | BTSG on Yahoo Finance (opens in a new tab) | Brightspring Health Svcs IncCOM | 0.7% | $121M | 1,732,800 | Added +7.2% | $40.92 | $60.48 | +47.8% |
| 32 | AZN on Yahoo Finance (opens in a new tab) | Astrazeneca PLCORD | 0.6% | $109M | 574,000 | Added +153.4% | $189.55 | $164.87 | -13.0% |
| 33 | JNJ on Yahoo Finance (opens in a new tab) | Johnson & JohnsonCOM | 0.6% | $104M | 408,000 | Added +175.7% | $230.64 | $255.21 | +10.7% |
| 34 | — | Strategy IncNOTE 12/0 | 0.4% | $75M | 87,858,000 prn | Added +122.4% | — | — | — |
| 35 | PBLS on Yahoo Finance (opens in a new tab) | Parabilis Medicines IncCOM | 0.4% | $65M | 2,368,200 | New | $27.62 | $23.77 | -13.9% |
| 36 | NVS on Yahoo Finance (opens in a new tab) | Novartis AGSPONSORED ADR | 0.3% | $57M | 363,000 | New | $149.91 | $150.88 | +0.6% |
| 37 | GH on Yahoo Finance (opens in a new tab) | Guardant Health IncCOM | 0.3% | $48M | 322,200 | Added +3927.5% | $108.20 | $159.15 | +47.1% |
| 38 | — | Vnet Group IncNOTE 2.000%10/0 | 0.3% | $47M | 45,000,000 prn | Unchanged | — | — | — |
| 39 | AVTX on Yahoo Finance (opens in a new tab) | Avalo Therapeutics IncCOM NEW | 0.3% | $46M | 2,498,000 | Added +172.7% | $15.74 | $11.35 | -27.9% |
| 40 | JOYY on Yahoo Finance (opens in a new tab) | Joyy IncADS REPSTG COM A | 0.3% | $46M | 699,200 | Added +20.9% | $42.67 | $82.77 | +94.0% |
| 41 | ASMB on Yahoo Finance (opens in a new tab) | Assembly Biosciences IncCOM NEW | 0.3% | $44M | 1,604,590 | Added +30.7% | $23.18 | $20.05 | -13.5% |
| 42 | ENTA on Yahoo Finance (opens in a new tab) | Enanta Pharmaceuticals IncCOM | 0.2% | $35M | 2,418,202 | Trimmed -15.8% | $12.33 | $11.21 | -9.1% |
| 43 | MAZE on Yahoo Finance (opens in a new tab) | Maze Therapeutics IncCOM | 0.2% | $33M | 1,107,814 | Added +197.0% | $32.24 | $27.24 | -15.5% |
| 44 | MRK on Yahoo Finance (opens in a new tab) | Merck & Co IncCOM | 0.1% | $26M | 199,000 | Trimmed -44.9% | $113.28 | $146.65 | +29.5% |
| 45 | WRBY on Yahoo Finance (opens in a new tab) | Warby Parker IncCL A COM | 0.1% | $25M | 828,000 | New | $24.76 | $23.92 | -3.4% |
| 46 | FRNM on Yahoo Finance (opens in a new tab) | Perceptive Cap Solutions CorCL A ORD SHS | 0.1% | $24M | 2,250,000 | Unchanged | $11.28 | $11.83 | +4.9% |
| 47 | KLRA on Yahoo Finance (opens in a new tab) | Kailera Therapeutics IncCOMMON STOCK | 0.1% | $24M | 1,100,000 | New | $21.98 | $11.49 | -47.7% |
| 48 | RIO on Yahoo Finance (opens in a new tab) | Rio Tinto PLCSPONSORED ADR | 0.1% | $17M | 183,475 | Added +241.0% | $95.77 | $90.50 | -5.5% |
| 49 | AXTA on Yahoo Finance (opens in a new tab) | Axalta Coating Sys LtdCOM | 0.1% | $16M | 478,000 | New | $30.08 | $33.53 | +11.5% |
| 50 | ABVX on Yahoo Finance (opens in a new tab) | Abivax SASPONSORED ADS | 0.1% | $16M | 122,000 | Added +6000.0% | $112.33 | $87.77 | -21.9% |
| 51 | VNET on Yahoo Finance (opens in a new tab) | Vnet Group IncSPONSORED ADS A | 0.1% | $16M | 1,992,000 | Added +219.6% | $8.74 | $4.01 | -54.0% |
| 52 | NTES on Yahoo Finance (opens in a new tab) | Netease Com IncSPONSORED ADS | 0.1% | $16M | 123,500 | Trimmed -57.6% | $121.85 | $126.19 | +3.6% |
| 53 | BIIB on Yahoo Finance (opens in a new tab) | Biogen IncCOM | 0.1% | $15M | 71,000 | New | $191.29 | $234.90 | +22.8% |
| 54 | TSHA on Yahoo Finance (opens in a new tab) | Taysha Gene Therapies IncCOM SHS | 0.1% | $15M | 2,250,000 | New | $5.92 | $3.63 | -38.7% |
| 55 | MOBI on Yahoo Finance (opens in a new tab) | Mobia Med IncCOMMON STOCK | 0.1% | $15M | 1,128,557 | New | $12.95 | $8.12 | -37.3% |
| 56 | — | Strategy IncNOTE 2.250% 6/1 | 0.1% | $14M | 15,000,000 prn | New | — | — | — |
| 57 | NERV on Yahoo Finance (opens in a new tab) | Minerva Neurosciences IncCOM NEW | 0.1% | $13M | 2,365,000 | Unchanged | $3.71 | $2.33 | -37.2% |
| 58 | ALMR on Yahoo Finance (opens in a new tab) | Alamar Biosciences IncCOMMON STOCK | 0.1% | $13M | 462,900 | New | $22.63 | $25.39 | +12.2% |
| 59 | ALVO on Yahoo Finance (opens in a new tab) | AlvotechORDINARY SHARES | 0.1% | $11M | 2,859,675 | Added +1332.2% | $4.13 | $4.97 | +20.1% |
| 60 | BBNX on Yahoo Finance (opens in a new tab) | Beta Bionics IncCOM | 0.1% | $9M | 595,000 | Trimmed -83.5% | $17.71 | $16.84 | -4.9% |
| 61 | IFRX on Yahoo Finance (opens in a new tab) | Inflarx NVCOM | 0.0% | $7M | 3,325,000 | New | $1.88 | $1.34 | -28.7% |
| 62 | SMG on Yahoo Finance (opens in a new tab) | Scotts Miracle-Gro CoCL A | 0.0% | $6M | 88,000 | New | $60.87 | $54.63 | -10.3% |
| 63 | WAY on Yahoo Finance (opens in a new tab) | Waystar Hldg CorpCOM | 0.0% | $5M | 264,900 | New | $21.03 | $27.57 | +31.1% |
| 64 | BC on Yahoo Finance (opens in a new tab) | Brunswick CorpCOM | 0.0% | $5M | 61,000 | New | $79.50 | $64.30 | -19.1% |
| 65 | GNTX on Yahoo Finance (opens in a new tab) | Gentex CorpCOM | 0.0% | $5M | 199,000 | New | $23.39 | $21.09 | -9.8% |
| 66 | IDXX on Yahoo Finance (opens in a new tab) | Idexx Labs IncCOM | 0.0% | $5M | 9,000 | New | $560.90 | $560.33 | -0.1% |
| 67 | PRME on Yahoo Finance (opens in a new tab) | Prime Medicine IncCOM | 0.0% | $5M | 1,240,843 | Unchanged | $4.62 | $3.52 | -23.8% |
| 68 | CMC on Yahoo Finance (opens in a new tab) | Commercial Metals CoCOM | 0.0% | $4M | 67,000 | New | $70.09 | $64.93 | -7.4% |
| 69 | JATT on Yahoo Finance (opens in a new tab) | Jatt II Acquisition CorpORD SHS | 0.0% | $3M | 300,000 | New | $10.63 | $10.25 | -3.6% |
| 70 | SGMT on Yahoo Finance (opens in a new tab) | Sagimet Biosciences IncCOM SER A | 0.0% | $3M | 415,000 | New | $6.80 | $8.02 | +17.9% |
| 71 | — | Strategy IncNOTE 3/0 | 0.0% | $2M | 2,632,000 prn | New | — | — | — |
| 72 | SMC on Yahoo Finance (opens in a new tab) | Summit Midstream CorporationCOM | 0.0% | $2M | 58,214 | Unchanged | $36.10 | $30.40 | -15.8% |
| 73 | TEVA on Yahoo Finance (opens in a new tab) | Teva Pharmaceutical Inds LtdSPONSORED ADS | 0.0% | $1M | 40,000 | Trimmed -88.7% | $30.52 | $41.03 | +34.4% |
| 74 | RVMDW on Yahoo Finance (opens in a new tab) | Revolution Medicines Inc*W EXP 12/17/202 | 0.0% | $1M | 120,085 | Unchanged | — | $8.41 | — |
| 75 | COGT on Yahoo Finance (opens in a new tab) | Cogent Biosciences IncCOM | 0.0% | $658K | 17,000 | Unchanged | $6.36 | $29.39 | +361.7% |
| 76 | ANNAW on Yahoo Finance (opens in a new tab) | Aleanna Inc*W EXP 12/13/202 | 0.0% | $297K | 990,000 | Unchanged | — | $0.24 | — |
| 77 | ANNA on Yahoo Finance (opens in a new tab) | Aleanna IncCOM CL A | 0.0% | $227K | 78,400 | Unchanged | $10.41 | $2.59 | -75.1% |
| 78 | WELL on Yahoo Finance (opens in a new tab) | Welltower IncCOM | 0.0% | $227K | 1,000 | Trimmed -99.5% | $184.49 | $234.12 | +26.9% |
| 79 | SLDPW on Yahoo Finance (opens in a new tab) | Solid Power Inc*W EXP 12/08/202 | 0.0% | $41K | 405,316 | Unchanged | — | $0.02 | — |
| 80 | BGLWW on Yahoo Finance (opens in a new tab) | Blue Gold Ltd*W EXP 04/01/203 | 0.0% | $31K | 255,800 | Trimmed -14.7% | — | $0.03 | — |
| 81 | PACB on Yahoo Finance (opens in a new tab) | Pacific Biosciences Calif InCOM | 0.0% | $24K | 14,200 | Trimmed -89.5% | $9.87 | $1.74 | -82.4% |
| 82 | GERN on Yahoo Finance (opens in a new tab) | Geron CorpCOM | 0.0% | $18K | 14,400 | Trimmed -66.5% | $3.16 | $1.18 | -62.6% |
| 83 | NVNWF on Yahoo Finance (opens in a new tab) | Nvni Group Limited*W EXP 11/01/202 | 0.0% | $18K | 375,000 | Unchanged | — | $0.01 | — |
| 84 | CGC on Yahoo Finance (opens in a new tab) | Canopy Growth CorporationCOM NEW | 0.0% | $17K | 18,000 | Trimmed -40.0% | $8.60 | $0.73 | -91.6% |
| 85 | RANI on Yahoo Finance (opens in a new tab) | Rani Therapeutics Hldgs IncCOM CL A | 0.0% | $16K | 20,700 | Trimmed -73.5% | $1.51 | $0.64 | -57.6% |
| 86 | BYND on Yahoo Finance (opens in a new tab) | Beyond Meat IncCOM | 0.0% | $14K | 19,000 | Unchanged | $86.87 | $6.80 | -92.2% |
Sold out since Q1 2026
- SCHW on Yahoo Finance (opens in a new tab)Schwab Charles Corp$372M at Q1 2026
- GOOG on Yahoo Finance (opens in a new tab)Alphabet Inc$286M at Q1 2026
- V on Yahoo Finance (opens in a new tab)Visa Inc$254M at Q1 2026
- DIS on Yahoo Finance (opens in a new tab)Disney Walt Co$231M at Q1 2026
- MA on Yahoo Finance (opens in a new tab)Mastercard Incorporated$217M at Q1 2026
- MCK on Yahoo Finance (opens in a new tab)McKesson Corp$203M at Q1 2026
- —Centessa Pharmaceuticals PLC$191M at Q1 2026
- TYRA on Yahoo Finance (opens in a new tab)Tyra Biosciences Inc$137M at Q1 2026
- THC on Yahoo Finance (opens in a new tab)Tenet Healthcare Corp$85M at Q1 2026
- CAH on Yahoo Finance (opens in a new tab)Cardinal Health Inc$78M at Q1 2026
- PCVX on Yahoo Finance (opens in a new tab)Vaxcyte Inc$73M at Q1 2026
- DNTH on Yahoo Finance (opens in a new tab)Dianthus Therapeutics Inc$70M at Q1 2026
- CGON on Yahoo Finance (opens in a new tab)Cg Oncology Inc$46M at Q1 2026
- BITW on Yahoo Finance (opens in a new tab)Bitwise 10 Crypto Index ETF$27M at Q1 2026
- RPRX on Yahoo Finance (opens in a new tab)Royalty Pharma PLC$24M at Q1 2026
- CECO on Yahoo Finance (opens in a new tab)Ceco Environmental Corp$14M at Q1 2026
- GDS on Yahoo Finance (opens in a new tab)GDS Hldgs Ltd$12M at Q1 2026
- FORM on Yahoo Finance (opens in a new tab)Formfactor Inc$5M at Q1 2026
- MTZ on Yahoo Finance (opens in a new tab)Mastec Inc$5M at Q1 2026
- ENTG on Yahoo Finance (opens in a new tab)Entegris Inc$5M at Q1 2026
- C on Yahoo Finance (opens in a new tab)Citigroup Inc$5M at Q1 2026
- H on Yahoo Finance (opens in a new tab)Hyatt Hotels Corp$5M at Q1 2026
- WAL on Yahoo Finance (opens in a new tab)Western Alliance Bancorp$5M at Q1 2026
- TKR on Yahoo Finance (opens in a new tab)Timken Co$5M at Q1 2026
- FLEX on Yahoo Finance (opens in a new tab)Flextronics Intl Ltd$5M at Q1 2026
- SPGI on Yahoo Finance (opens in a new tab)S&P Global Inc$5M at Q1 2026
- LFUS on Yahoo Finance (opens in a new tab)Littelfuse Inc$5M at Q1 2026
- PIPR on Yahoo Finance (opens in a new tab)Piper Sandler Companies$5M at Q1 2026
- AIR on Yahoo Finance (opens in a new tab)Aar Corp$5M at Q1 2026
- GTX on Yahoo Finance (opens in a new tab)Garrett Motion Inc$5M at Q1 2026
- ROL on Yahoo Finance (opens in a new tab)Rollins Inc$5M at Q1 2026
- AFRM on Yahoo Finance (opens in a new tab)Affirm Hldgs Inc$5M at Q1 2026
- INTR on Yahoo Finance (opens in a new tab)Inter & Co Inc$5M at Q1 2026
- CMI on Yahoo Finance (opens in a new tab)Cummins Inc$5M at Q1 2026
- FISV on Yahoo Finance (opens in a new tab)Fiserv Inc$5M at Q1 2026
- VRT on Yahoo Finance (opens in a new tab)Vertiv Holdings Co$5M at Q1 2026
- AMKR on Yahoo Finance (opens in a new tab)Amkor Technology Inc$5M at Q1 2026
- RNA on Yahoo Finance (opens in a new tab)Atrium Therapeutics Inc$5M at Q1 2026
- GFS on Yahoo Finance (opens in a new tab)Globalfoundries Inc$5M at Q1 2026
- MOH on Yahoo Finance (opens in a new tab)Molina Healthcare Inc$5M at Q1 2026
Estimated, from reported holdings
Quarter by quarter
High-conviction buys (new positions at 3% or more of the portfolio) since Q1 2022: 11. Of 5 with six months of history, 20.0% beat the S&P 500 from the filing date.
Source: SEC Form 13F-HR 0000908834-26-000432, compared with the Q1 2026 report. 3 option rows are excluded from weights. Tickers map from CUSIP via OpenFIGI. Estimated returns weight each position’s next-quarter total return (Yahoo Finance adjusted closes) by its quarter-end value and assume no trades. Estimated cost averages daily adjusted closes in each quarter the share count rose, from Q1 2022 onward (* = held at the start of our data). Price is the latest close.
Important information
Form 13F data is delayed. Managers have up to 45 days after each calendar quarter to file, so holdings shown may have changed materially since the report date. 13F reports cover long positions in US-listed equities and certain other securities only; they exclude short positions, most non-US holdings, cash, bonds and private investments, and managers may request confidential treatment for some positions. Options rows are listed in filings but are not counted in the holdings and weights shown here.
Estimated holdings returns, estimated cost and high-conviction results are hypothetical calculations from quarter-end holdings and public prices, assuming no trades between reports. They are not the actual returns or costs of any fund or manager and do not reflect fees, trading, leverage, shorts or cash. Biographies are drawn from cited public sources. This page is for information only and is not individualized investment advice or a recommendation to buy or sell any security. Gulfstream Capital and its clients may hold positions in securities shown.